Zetia vs. Livalo

See how Zetia and Livalo compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Zetia blocks cholesterol absorption in the gut, while Livalo is a statin that blocks cholesterol production in the liver.

  • Zetia is often added to a statin like Livalo for extra LDL lowering, since the two work through different mechanisms.

  • Livalo requires liver and muscle monitoring typical of statins, while Zetia has a lower risk of muscle-related side effects on its own.

Zetia vs. Livalo Drug Summary

Zetia

Zetia (ezetimibe) is a cholesterol absorption inhibitor that lowers LDL cholesterol by blocking its uptake in the small intestine. It is FDA-approved as an add-on to diet, either alone or combined with a statin, for adults and certain pediatric patients with high cholesterol. It is taken as one 10 mg tablet by mouth once a day.

Livalo

Livalo (pitavastatin) is a statin that lowers LDL cholesterol by blocking an enzyme the liver uses to make cholesterol. It is FDA-approved as an add-on to diet for adults with high cholesterol and for children 8 and older with familial hypercholesterolemia. It is taken as one tablet by mouth once a day, at a dose of 1 mg, 2 mg, or 4 mg.

Zetia vs. Livalo Side Effects

Zetia

Most common
upper respiratory tract infection (up to 4.3%)
diarrhea (up to 4.1%)
arthralgia (up to 3.0%)
sinusitis (up to 2.8%)

Livalo

Most common
myalgia (1.9% to 3.1%)
diarrhea (1.5% to 2.6%)
constipation (1.5% to 3.6%)
back pain (1.4% to 3.9%)

Zetia vs. Livalo Dosage

Zetia

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 10 mg once daily At the start
Maximum dose 10 mg once daily Same as starting
Dose changes None Fixed dose

Livalo

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 1 mg once daily At the start
Maximum dose 4 mg once daily If needed
Dose changes 2 increases As tolerated

Zetia vs. Livalo Indications

Zetia

Zetia is approved to lower LDL cholesterol in adults with high cholesterol, either used alone or added to a statin. It also has specific approvals for certain inherited cholesterol disorders and for mixed hyperlipidemia when combined with fenofibrate.

  • Primary hyperlipidemia, alone or with a statin

  • Heterozygous familial hypercholesterolemia in patients 10+, with a statin

  • Mixed hyperlipidemia, in combination with fenofibrate

  • Homozygous familial hypercholesterolemia in patients 10+, with a statin

Livalo

Livalo is approved to lower LDL cholesterol, total cholesterol, apolipoprotein B, and triglycerides in adults with high cholesterol. It is also approved for a genetic form of high cholesterol in children as young as 8. It is sometimes used off-label for primary prevention of cardiovascular disease.

  • Primary hyperlipidemia or mixed dyslipidemia

  • Heterozygous familial hypercholesterolemia in adults

  • Heterozygous familial hypercholesterolemia in children 8+

  • Off-label: primary prevention of cardiovascular disease

Zetia vs. Livalo Pros and Cons

Zetia

Zetia works through a different pathway than statins, so it is commonly added to a statin for extra LDL lowering without extra muscle risk. Generic ezetimibe is widely available and inexpensive, making it an accessible add-on therapy.

Pros

  • Non-statin mechanism, useful when statins alone are not enough

  • Lower risk of muscle-related side effects than statins

  • Generic version available, roughly $8 to $50 a month

  • Simple single 10 mg dose with no titration needed

Cons

  • Less potent than a statin when used by itself

  • Not approved as monotherapy for homozygous familial hypercholesterolemia

  • Muscle and liver risks rise when combined with a statin or fibrate

Livalo

Livalo lowers LDL cholesterol directly by inhibiting its production in the liver, with flexible dosing from 1 mg to 4 mg. It has minimal CYP3A4 metabolism, which means fewer drug interactions than some other statins, but no generic version keeps its cost higher.

Pros

  • Directly lowers LDL, total cholesterol, and triglycerides on its own

  • Three dose strengths allow gradual titration

  • Fewer CYP3A4 drug interactions than many other statins

  • No FDA boxed warning, unlike some other statins historically

Cons

  • Carries statin-class risk of myopathy and rhabdomyolysis

  • No generic version, roughly $315 to $410 a month

  • Not approved for use during pregnancy

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.